ReviewRheumatology and immunology research2022

Interleukin-6 blocking therapy for COVID-19: From immune pathogenesis to clinical outcomes.

Fan Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.